Your browser doesn't support javascript.
loading
Association Between Doses of Levonorgestrel Intrauterine Systems and Subsequent Use of Psychotropic Drugs in France.
Roland, Noémie; Baricault, Bérangère; Weill, Alain; Bouillon, Kim; Dray-Spira, Rosemary; Duranteau, Lise; Zureik, Mahmoud.
Affiliation
  • Roland N; EPI-PHARE (ANSM/CNAM), Saint-Denis, France.
  • Baricault B; EPI-PHARE (ANSM/CNAM), Saint-Denis, France.
  • Weill A; EPI-PHARE (ANSM/CNAM), Saint-Denis, France.
  • Bouillon K; EPI-PHARE (ANSM/CNAM), Saint-Denis, France.
  • Dray-Spira R; EPI-PHARE (ANSM/CNAM), Saint-Denis, France.
  • Duranteau L; Department of Medical Gynecology, Le Kremlin Bicêtre Hospital, Paris, France.
  • Zureik M; EPI-PHARE (ANSM/CNAM), Saint-Denis, France.
JAMA ; 329(3): 257-259, 2023 01 17.
Article in En | MEDLINE | ID: mdl-36548007
This matched-cohort study uses data from the French National Health Insurance database to assess whether a 19.5-mg levonorgestrel intrauterine system, vs a 52-mg system, is associated with increased use of antidepressant, hypnotic, and anxiolytic medications.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotropic Drugs / Levonorgestrel / Intrauterine Devices, Medicated Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: JAMA Year: 2023 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotropic Drugs / Levonorgestrel / Intrauterine Devices, Medicated Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: JAMA Year: 2023 Document type: Article Affiliation country: France Country of publication: United States